Spotlight
Patrick W. Serruys, on behalf of the SPIRIT II Investigators, Erasmus University Thorax Center, Rotterdam, The Netherlands
The SPIRIT II study is a 300 patient multi-center, randomized (3:1), single-blind, controlled study. The purpose of the SPIRIT II study is a continuation in the assessment of the safety and performance of the Abbott Vascular XIENCE V Everolimus Eluting Coronary Stent System (EECSS) in the treatment of patients with a maximum of two de novo native coronary artery lesions located in two diff... More »